Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01563991 · ClinicalTrials.gov registry record · NA
Impact of Perioperative Intravenous Fluid Utilization on Postoperative Outcomes
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 186
- Enrollment target
NCT01563991: Completed NA study, sponsored by The Cleveland Clinic.
NCT01563991 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 186 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01563991, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 186 participants
- Enrollment target
Study Summary
Subjects undergoing surgery on the small or large bowel will be randomized to one of 2 groups, a normal fluid amount group and a reduced fluid amount group to evaluate the impact of this change on recovery after surgery.
Primary Outcome
Reduction in post-operative complications at the time of hospital discharge after the surgical episode
Interventions
- PROCEDURE Normal fluid volume
- PROCEDURE Reduced fluid volume
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2007-02 |
| Est. Completion | 2012-04-18 |
| Phase | NA |
What the finished NCT01563991 record still lists
NCT01563991 is an interventional study that assigns participants to a tested intervention. The registered 186 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which Normal fluid volume is the first listed.
NCT01563991 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01563991 about?
NCT01563991 is a clinical study titled "Impact of Perioperative Intravenous Fluid Utilization on Postoperative Outcomes". Subjects undergoing surgery on the small or large bowel will be randomized to one of 2 groups, a normal fluid amount group and a reduced fluid amount group to evaluate the impact of this change on recovery after surgery.
What is the current status of trial NCT01563991?
This trial is currently completed. It is a NA study. The enrollment target is 186 participants. The study started on 2007-02. Estimated completion is 2012-04-18.
What interventions are being tested in trial NCT01563991?
The interventions under investigation include: Normal fluid volume (PROCEDURE), Reduced fluid volume (PROCEDURE).
Who is sponsoring clinical trial NCT01563991?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01563991's enrollment target sits among peer trials
186 579th of 2000 higher than 1,421 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03567889 · 186 participants · Phase 3
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
- NCT05281471 · 186 participants · Phase 3
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
- NCT05405595 · 186 participants · Phase 1
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
- NCT05762107 · 186 participants · Phase 2
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia